Saxenda (liraglutide)

pCPA File Number: 21602
Negotiation Status:
Under consideration for negotiation
Indication(s):
chronic weight management
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CADTH Project Number:
SR0668-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable